Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5081959
Max Phase: Preclinical
Molecular Formula: C77H110N18O17S2
Molecular Weight: 1623.97
Molecule Type: Unknown
Associated Items:
ID: ALA5081959
Max Phase: Preclinical
Molecular Formula: C77H110N18O17S2
Molecular Weight: 1623.97
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2
Standard InChI: InChI=1S/C77H110N18O17S2/c1-6-44(4)62-73(109)91-56-41-113-114-42-57(90-65(101)49(28-18-32-81-77(79)80)83-60(97)40-82-64(100)54(39-61(98)99)87-71(107)58-29-19-34-95(58)76(112)55(89-69(56)105)38-48-25-14-9-15-26-48)70(106)93-63(45(5)96)74(110)88-53(37-47-23-12-8-13-24-47)68(104)86-52(36-46-21-10-7-11-22-46)67(103)85-51(35-43(2)3)66(102)84-50(27-16-17-31-78)75(111)94-33-20-30-59(94)72(108)92-62/h7-15,21-26,43-45,49-59,62-63,96H,6,16-20,27-42,78H2,1-5H3,(H,82,100)(H,83,97)(H,84,102)(H,85,103)(H,86,104)(H,87,107)(H,88,110)(H,89,105)(H,90,101)(H,91,109)(H,92,108)(H,93,106)(H,98,99)(H4,79,80,81)/t44-,45+,49-,50+,51+,52+,53+,54-,55-,56-,57-,58-,59-,62-,63-/m0/s1
Standard InChI Key: VGHQURARGWZGAC-VOHFEYLYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1623.97 | Molecular Weight (Monoisotopic): 1622.7738 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Muratspahić E, Tomašević N, Koehbach J, Duerrauer L, Hadžić S, Castro J, Schober G, Sideromenos S, Clark RJ, Brierley SM, Craik DJ, Gruber CW.. (2021) Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain., 64 (13.0): [PMID:34162205] [10.1021/acs.jmedchem.1c00158] |
Source(1):